drugset
drugset / Trial / NCT02106871

Study of Sildenafil as a Therapy for Fatigue in Pancreatic Cancer

NCT02106871 ↗

Phase 1 Withdrawn The University of Texas Medical Branch, Galveston
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Investigation of the effects of daily sildenafil on patients with pancreatic or cholangiocarcinoma cancer undergoing treatment.

Timeline

Start
2014-04
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg —

Indications

cholangiocarcinoma malignant pancreatic neoplasm